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It has been established that amyloid β (Aβ) deposits
in the brain, as senile plaques (SPs) and cerebral
amyloid angiopathies (CAAs), are histopatho-
logical hallmarks of Alzheimer's disease (AD)
(Mandybur, 1975; Griffiths et al., 1982; Miyakawa
et al., 1982; Vinters et al., 1996; Jellinger, 2002),
and that CAA alone may give rise to dementia in the
elderly without AD pathology (Cohen et al., 1997;
Yamada et al., 1997; Vidal et al., 2000; Kalaria, 2002).
In the pathological investigations of AD and CAA,
a great number of studies have focused on SPs and
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Immunohistochemical study of perivascular plaques (PPs) in 7 patients with Alzheimer’s
disease (AD) and 4 with cerebral amyloid angiopathy (CAA)(CAA with dementia in 3 pa-
tients and CAA with massive cerebral hemorrhage in 1 patient) demonstrated that PPs
were also a common form of amyloid β (Aβ) deposits, like SPs and CAAs, in both AD and
CAA, and that they had similar immunostaining characteristics to mature senile plaques
(SPs), manifesting as always positive for both Aβ42 and Aβ40 but predominant for Aβ42.
In addition, PPs were always associated with AT8-positive degenerated neurites and GFAP-
positive astrocytes and fibers.  These findings suggest that PPs as mature plaques contribute
to the development of dementia, especially in CAA with dementia which lack AD pathology.
Moreover, semiquantitative analysis revealed no correlation between the number of PPs
and that of SPs, but a good correlation between the number of PPs and that of CAAs,
suggesting that there was a close relationship of the formation of PPs and the development
of CAAs.  PPs were also found around non-CAA arteries, although they were frequent
around varying degrees of CAAs, suggesting that the initial Aβ42 deposits in PPs contribute
to the development of CAAs.
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CAAs (Alonzo et al., 1998; Iwatsubo et al., 1994,
1995), and elucidated that Aβ42 deposition is pre-
dominant in SPs and Aβ40 in CAAs.  However, an-
other form of Aβ deposition, perivascular plaques
(PPs) have not yet been studied thoroughly.  PPs
were first described by Uematsu (1923) as perivascu-
lar form of SPs and then by Scholz (1938) as drusige
Entartung (in German).  Morel and Wildi (1952) used
the term dyshoric angiopathy which meant a break-
down of the blood-brain barrier.  Previous research-
ers thought that amyloid in PPs extended from the vas-
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cular wall of CAAs to the surrounding parenchyma
in the cerebral cortex (Neumann, 1960; Mandybur,
1986; Plant et al., 1990).  Some recent studies have
raised the hypothesis that Aβ is eliminated along
perivascular interstitial fluid drainage pathways of
the brain and progressively accumulates to form
PPs, and further contributes to CAAs (Weller et al.,
1998, 2000; Kalaria, 2002; Kumar-Singh, 2002;
Yow and Weller, 2002).  However, immunohisto-
chemical studies focusing on PPs have not ever
been reported.  For the purpose of clarifying the
neuropathological significance of PPs, we examin-
ed the brains of patients with AD and CAA by im-
munohistochemistry, and investigated the relation-
ship of PPs to SPs and CAAs.
Subjects and Methods
Brain tissues were obtained from 7 patients with
AD, 3 patients with CAA with dementia (CAA-D)
and 1 patient with CAA with massive cerebral hem-
orrhage (CAA-CH).  All patients were brought to
autopsy and neuropathological examination in the
Department of Neuropathology, Institute of Neuro-
logical Sciences, Tottori University Faculty of Medi-
cine, Japan.  All tissue specimens were fixed in 10%
formalin for 2 weeks, embedded in paraffin and cut
into 6-µm-thick sections.  Routine neuropatho-
logical examinations were carried out with hema-
toxylin and eosin, Klüver-Barrera, Bielshowsky,
Gallyas-Braak and Holzer stains.  Summary of clin-
ical and routine neuropathological features are
shown in Table 1.
For immunohistochemistry in the present
study, samples were selected from the occipital and
temporal lobes including the Ammon’s horn and se-
rial sections were made.  The sections were immuno-
stained with the following primary antibodies:  anti-
pan Aβ (Aβ-1) (polyclonal, Wako, Osaka, Japan;
dilution 1:1000); anti-Aβ42 (BC05) and -Aβ40
(BA27) (monoclonal, Wako; Aβ Immunohistostain
Kit); anti-human apolipoprotein E4 (ApoE4) (5B5)
(monoclonal, IBL, Fujioka, Japan; dilution 1:10);
anti-human smooth muscle actin (1A4) (monoclon-
al, DAKO A/S, Copenhagen, Denmark; dilution
1:50); anti-glial fibrillary acidic protein (GFAP)
(polyclonal, DAKO A/S; dilution 1:1000); and anti-
human phosphorylated tau (AT8) (monoclonal,
Innogenetics, NV, Ghent, Belgium; dilution 1:1000).
Immunostainings were performed by the avidin-
biotin-peroxidase complex (ABC) method.  Sec-
tions mounted on poly-L-lysine-coated glass slides
were deparaffinized, rehydrated in a graded ethanol
series, washed in distilled water for 10 min, and
treated with 3% hydrogen peroxide diluted in dis-
tilled water for 30 min to block endogenous peroxi-
dase activity in the tissue.  After washing in 0.01 M
phosphate-buffered saline (PBS) pH 7.4 for 10 min,
the sections were resubjected to blocking with 10%
normal serum (Nichirei, Tokyo, Japan) for 30 min
to avoid nonspecific binding of secondary anti-
bodies.  The sections were then incubated overnight
with the primary antibodies in a moist chamber at
4˚C.  After washing 3 times with PBS (5 min each)
the sections were incubated with appropriate sec-
ondary antibodies for 60 min at room temperature,
treated with the ABC reagent for 60 min, exposed to
0.5% 3,3'-diaminobenzidine-0.005% hydrogen per-
oxide.  For enhancement of Aβ and ApoE4 immuno-
staining, deparaffinized tissue sections were pretreated
with 96% fomic acid for 5 min.  The sections were
heated up to 110˚C for 10 min to improve ApoE4 im-
munostaining.  Finally, sections were counterstained
with hematoxylin.
Neurofibrillary tangles (NFTs) were counted
in 5 nonselected × 100 fields in the Ammon’s horn
and subiculum in Bielschowsky stain, and were
rated as follows:  +, 1–10; ++, 11–50 and +++, ≥ 51.
Quantitative analysis of SPs was performed based
on the number of mature and diffuse plaques in the
temporal cortices in Aβ42 and Aβ40 immuno-
stainings in 10 nonselected × 100 fields.  The abun-
dance of SPs was rated as follows:  +, 1–10; ++, 11–
50 and  +++, ≥ 51.  The rating of CAA severity was
made based on the number of pan Aβ-positive ves-
sels in the occipital cortices with 10 nonselected ×
40 fields:  +, 1–5 positive vessels; ++, 6–10 positive
vessels and +++, ≥ 11 positive vessels and at least 1
vessel showing complete replacement of the media
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with Aβ.  The rating of PPs severity was determined
as follows:  +, 1–3; ++, 4–6 and +++, ≥ 7 in 10 non-
selected × 40 fields in the occipital cortices.
Results
Immunohistochemistry of PPs
PPs were found in all 11 patients.  In AD, they were
small in number compared with SPs, but were nu-
merous in CAA-D and CAA-CH in which mature
plaques were absent and only a small number of
diffuse plaques were found in 3 of the 4 patients
(Table 2).
PPs were always immunostained for both
Aβ42 and Aβ40, but their number and positive-
staining areas were always greater in Aβ42 staining
(Table 2, Figs. 1A and B), suggesting earlier depo-
sition of Aβ42 than Aβ40 similar to mature plaques.
All PPs were always associated with varying de-
grees of neuritic degeneration evidenced by AT8
immunostaining (Fig. 1C) as well as Gallyas-Braak
and Bielshowsky stains and with GFAP-positive cells
and fibers within or around them as well (Fig. 1D).
These features are again similar to mature plaques.
PPs were ApoE4-positive in AD patients 1 and 2
and CAA-D patient 1, and in these 3 patients SPs
and CAAs were also positive for ApoE4 (Fig. 1E).
Thus, PPs resembled mature plaques in that they
were always positive for both Aβ42 and Aβ40, and
that they were always associated with degenerated
neurites and GFAP-positive cells and fibers.  Their
incidence was not proportional to that of mature and
diffuse plaques but proportional to CAAs (Table 2).
Although they were more frequent around varying
degrees of CAAs (Figs. 1A, B and F), they were
also found around non-CAA vessels (Fig. 1G), sug-
gesting that PPs were formed earlier than CAAs.
Immunohistochemistry of CAAs
Different numbers of CAAs were found in all 7 AD
patients:  moderate in 3 and mild in 4 patients.  They
were marked in 3 CAA-D patients and moderate in
1 CAA-CH patient (Table 1).  There was a good cor-
relation in the severity of CAAs between the lepto-
mengeal and parenchymal blood vessels.  CAA-
Table 1.  Summary of clinical and pathological features of 11 cases examined
Age at death Duration of   Brain weight Rating*
             Patient (year) Gender  illness (year)    (g) NFT SP CAA
Alzheimer’s disease 1 57 F 5   — ++ +++ +
2 67 F 7   — ++ +++ ++
3 75 F 2 1180 ++ +++ ++
4 56 F 4   — ++ +++ +
5 89 F 6 1060 ++ +++ +
6 83 M 4 1400 ++ +++ +
7 79 F 8   860 ++ +++ ++
CAA with dementia (D) 1 76 M 5 1205 + + +++
2 68 M 16 1360 + + +++
3 62 F 7 1360 + + +++
CAA with massive cerebral hemorrhage (CH)
1 75 F 0.25   860 + + ++
CAA, cerebral amyloid angiopathy; F, female; M, male; NFT, neurofibrillary tangle; SP, senile plaque; —, not
weighed.
*NFT: +, 1–10; ++, 11–50; +++, ≥51 in   5 × 100 fields in the Ammon’s horn and subiculum.
SP: +, 1–10; ++, 11–50; +++, ≥51 in 10 × 100 fields in the temporal cortices.
CAA: +, 1–  5; ++,   6–10; +++, ≥11 in 10 ×   40 fields in the occipital cortex.
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Table 2.  Immunohistochemical features of  senile plaque (SP), cerebral amyloid angiopathy (CAA)
and perivascular plaque (PP)
                                                                                                      Rating*
                                                                                 SP
                                               Mature plaque       Diffuse plaque
                              Aβ42+            Aβ42+         CAA         PP
              Patient                             Aβ40+       AT8 Aβ40–       AT8          Aβ42   Aβ40     Aβ42   Aβ40   AT8
Alzheimer’s disease 1 +++ + ++ – + + + + +
2 +++ + +++ – ++ ++ ++ + +
3 +++ + +++ – ++ ++ ++ + +
4 ++ + +++ – + + + + +
5 ++ + +++ – + + + + +
6 + + +++ – + + + + +
7 ++ + +++ – ++ ++ ++ ++ +
CAA with dementia (D) 1 – – ++ – +++ +++ +++ +++ +
2 – – + – +++ +++ +++ +++ +
3 – – + – +++ +++ +++ +++ +
CAA with massive cerebral hemorrhage (CH)
1 – – + – ++ ++ ++ ++ +
Aβ40, amyloid β40 protein; Aβ42, amyloid β42 protein; AT8, anti-human phosphorylate α tau.
* SP: +, 1–10; ++, 11–50; +++, ≥51 in 10 × 100 fields in the temporal cortices.
CAA: +, 1–  5; ++,   6–10; +++, ≥11 in 10 ×  40 fields in the occipital cortices.
PP: +, 1–  3; ++,   4–  6; +++,   ≥7 in 10 ×  40 fields in the occipital cortices.
AT8: +, positive; –,  negative.
associated vasculopathies such as double barreling
and clusters of multiple arteriolar lumina were seen
in the 3 CAA-D patients.
CAAs were always labeled with both Aβ42
and Aβ40 (Table 2).  Their staining intensity and
positive-staining areas were, however, greater with
Aβ40 in larger cortical and leptomeningeal arteries
(Figs. 1A and B; Figs. 2A and B), but were greater
with Aβ42 in smaller cortical arteries (Figs. 2A and
B; arrows).  In the same vessel wall, the 2 Aβ spe-
cies were sometimes detected in different areas.  In
larger leptomeningeal arteries, early small deposits
of Aβ42 were always observed at the media adja-
cent to the adventitia (Fig. 2A) or sometimes at the
Figs. 1A–G (p. 13).  Immunohistochemistry of perivascular plaques (PPs).
A: Immunostaining for amyloid β42 (Aβ42), showing positive PPs. The occipital cortex in Alzheimer’s disease (AD)
(Patient 2).
B: An adjacent section to A immunostained with Aβ40.  Positive areas are smaller in the PPs but larger in the artery
compared with A.
C: An adjacent section to A immunostained with AT8, showing degenerated neurites within or around the PPs.
D: GFAP-immunostaining of another serial section, showing numerous positive cells and fibers within and around
the PPs.
E: A serial section of A immunostained with ApoE4.  The staining pattern of the PPs is similar to B but the artery is
intensely positive.
F: Immunostaining for Aβ42, showing positive PPs and artery.  The occipital cortex of AD (Patient 7).
G: Immunostaining for pan Aβ (Aβ42 and Aβ40), showing PP around non-CAA artery.
A–G: original magnification, × 100.  AT8, anti-human phosphorylated tau; ApoE4, apolipoprotein E4; CAA,
cerebral amyloid angiopathy; GFAP, glial fibrillary acidic protein.






C. H. Yang et al.
14
Fig. 2A–D.  Immunohistochemistry of cerebral amyloid angiopathies (CAAs).
A: Immunostaining for amyloid β42 (Aβ42).  In larger meningeal arteries, small positive areas are limited to the
media adjacent to the adventitia but smaller cortical arteries are intensely stained in their whole walls (arrows).
The occipital cortex in Alzheimer’s disease (AD) (Patient 2).
B: An adjacent section immunostained with Aβ40.  Positive areas are larger than Aβ42 but smaller cortical arteries
are negative (arrows).  A, B:  original magnification, × 40.
C: Immunostaining for Aβ40 of an artery in the occipital cortex, showing complete replacement of the wall by Aβ40.
The occipital cortex from AD (Patient 3).
D: An adjacent section to C, showing complete abscence of α-smooth muscle actin immunoreactivity in the media.
C, D:  original magnification, × 100.
  A    B
C     D
adventitia as well.  As the amount of amyloid depo-
sition increased, the deposits extended more to part
of the media and eventually to the whole vessel
wall, which were clearly demonstrated as absence
of smooth muscle actin immunoreactivity in the
media (Figs. 2C and D).  Early small amyloid depos-
its were never observed in the vicinity of the endo-
thelium or the internal elastic lamina.
The relationship of PPs to SPs and CAAs
In AD patients, there were many mature plaques not
only in the neuropil but also around blood vessels or
adjacent to PPs, but diffuse plaques were not assoc-
iated with blood vessels.  There was no correlation
between the number of PPs and that of SPs, but a
good correlation was noted between the number of
PPs and CAAs in AD and CAA patients (Table 2).
Figs. 2A–D
Immunohistochemistry of perivascular plaque
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Discussion
Uematsu (1923) first described PPs as a perivascu-
lar form of SPs.  Thereafter Scholz (1938) described
PPs as drusige Entartung in German, SP-like angio-
pathy in English.  He reported the small argyro-
philic material resembling SPs initially deposits at
the outer part of the media of the cortical arteries,
extends to the adventitia and then eventually to the
perivascular brain tissues.  After Scholz, there have
been few studies focusing on PPs and the neuro-
pathological significance of PPs has not yet been
elucidated.
In this immunohistochemical study, we found
PPs were also a common form of Aβ deposits like
SPs and CAAs in AD and CAA patients.  They were
always immunostained with Aβ42 and Aβ40, but
their positive-staining areas were always larger in
Aβ42 staining.  In addition, they were always asso-
ciated with AT8-positive, degenerated neurites and
also with GFAP-positive astrocytes and astrocytic
fibers within and around them.  All of these im-
munohistochemical features are the same as mature
SPs, indicating that PPs are another form of mature
plaque.
PPs were much more frequent in CAA, partic-
ularly in CAA-D in which CAAs were remarkably
numerous but the number of both NFTs and SPs
was within range of physiological aging.  Further-
more, our semiquantitative analysis revealed no
correlation between the number of PPs and that of
SPs but a good correlation between the number of
PPs and that of CAAs.  These findings suggest that
PPs may play an important role in the pathogenesis
of dementia, especially in CAA-D, and that there is
a close relationship between the formation of PPs
and the development of CAAs.
Neither the exact origin of Aβ in PPs and CAAs
nor the mechanism by which it is deposited has as
yet been resolved.  Mandypur (1975) described that
amyloid appeared in the neuropil along arterioles or
in the Virchow-Robin spaces in the cerebral cortex,
but the vessel wall itself was not necessarily involv-
ed.  Some recent studies raised the hypothesis that
Aβ was deposited initially in periarterial interstitial
fluid drainage pathways of the cerebral cortex and
contributed to CAAs in AD (Weller et al., 1998,
2000; Yow et al., 2002).  Our results support this
hypothesis from 2 aspects.  First, PPs were also
found around non-CAA arteries in AD and CAA
patients, although they were frequently seen around
varying degrees of CAAs.  This finding suggests
that the formation of PPs precedes the development
of CAAs.  Second, the main component of Aβ in
PPs was Aβ42, and the early Aβ deposits in the vas-
cular wall was also Aβ42, suggesting that Aβ in the
vascular wall came from PPs, which was subse-
quently followed by Aβ40.  Yamaguchi et al. (1992)
also reported the same results in an immunoelectron
microscopic study.  In addition, Frautschy et al.
(1992) also supported the hypothesis from their ob-
servations in animal experiments where direct in-
jection into rat brains of isolated amyloid plaque
cores had migrated to vessel walls and ventricular
linings, implying that the distribution of injected
amyloid is not necessarily comparable to the initial
site of its deposition.  Our 2 findings, together with
other previous reports, were consistent with the Aβ
deposit pathway described by Weller et al. (1998,
2000).
In summary, the present study demonstrated
some immunohistochemical characteristics of PPs:
they are immunopositive for Aβ42 and Aβ40,
predominant for Aβ42, and always associated with
degenerated neurites and reactive astrocytosis.
These findings suggest that PPs were another form
of mature plaque and that they may contribute to the
development of dementia, particularly in CAA-D,
and to the formation of CAAs.
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